Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?
作者信息
Cottin Vincent, Brown Kevin K, Flaherty Kevin R, Wells Athol U
机构信息
Claude Bernard University Lyon 1 Lyon, France.
Louis Pradel Hospital Lyon, France.
出版信息
Am J Respir Crit Care Med. 2022 Nov 15;206(10):1293-1294. doi: 10.1164/rccm.202206-1143LE.
Abstract
摘要
相似文献
1
Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?进行性肺纤维化：是否应从定义中去除时间线？
Am J Respir Crit Care Med. 2022 Nov 15;206(10):1293-1294. doi: 10.1164/rccm.202206-1143LE.
2
Progressive fibrosis in interstitial lung diseases - proposed definition and management.间质性肺疾病的进行性纤维化 - 建议的定义和管理。
Adv Respir Med. 2021;89(5):505-510. doi: 10.5603/ARM.a2021.0103.
3
Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis.特发性肺纤维化和进行性肺纤维化。
Immunol Allergy Clin North Am. 2023 May;43(2):209-228. doi: 10.1016/j.iac.2023.01.010. Epub 2023 Mar 3.
4
Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults.成人特发性肺纤维化（最新进展）及进行性肺纤维化述评
Am J Respir Crit Care Med. 2022 Nov 15;206(10):1296. doi: 10.1164/rccm.202207-1260LE.
5
2022 update on clinical practice guidelines for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.《特发性肺纤维化和进行性肺纤维化临床实践指南2022年更新》
Lancet Respir Med. 2022 Aug;10(8):729-731. doi: 10.1016/S2213-2600(22)00223-5. Epub 2022 Jun 24.
6
A case of progressive lung fibrosis.进行性肺纤维化 1 例。
Am J Med Sci. 2011 Jun;341(6):428-30. doi: 10.1097/MAJ.0b013e31821a9d52.
7
[Pharmacological treatment of idiopathic pulmonary fibrosis (update) and progressive pulmonary fibrosis - S2k Guideline of the German Respiratory Society].[特发性肺纤维化的药物治疗（更新版）及进行性肺纤维化——德国呼吸学会S2k指南]
Pneumologie. 2023 Feb;77(2):94-119. doi: 10.1055/a-1983-6796. Epub 2023 Feb 15.
8
Update on diagnosis and treatment of idiopathic pulmonary fibrosis.特发性肺纤维化的诊断与治疗进展
J Bras Pneumol. 2015 Sep-Oct;41(5):454-66. doi: 10.1590/S1806-37132015000000152.
9
Idiopathic pulmonary fibrosis.特发性肺纤维化。
Immunol Allergy Clin North Am. 2012 Nov;32(4):473-85. doi: 10.1016/j.iac.2012.08.006. Epub 2012 Sep 14.
10
Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective.所有特发性肺纤维化患者都需要进行治疗干预试验吗？赞成与反对的观点。
Respirology. 2015 Apr;20(3):389-94. doi: 10.1111/resp.12484. Epub 2015 Feb 26.
引用本文的文献
1
Progressive pulmonary fibrosis: current perspectives in diagnostic imaging.进行性肺纤维化：诊断成像的当前观点
BJR Open. 2025 Jul 24;7(1):tzaf018. doi: 10.1093/bjro/tzaf018. eCollection 2025 Jan.
2
Initiation of antifibrotic treatment in fibrosing interstitial lung disease: is the clock ticking till proven progression?纤维化间质性肺疾病抗纤维化治疗的启动：在证实疾病进展之前，时间是否紧迫？
Eur Respir Rev. 2025 Aug 6;34(177). doi: 10.1183/16000617.0023-2025. Print 2025 Jun.
3
Insights from the INSIGHTS-ILD Registry: real-world heterogeneity in treatment patterns for patients with fibrotic interstitial lung disease.来自INSIGHTS-ILD注册研究的见解：纤维化间质性肺疾病患者治疗模式的真实世界异质性
ERJ Open Res. 2025 Jun 9;11(3). doi: 10.1183/23120541.01395-2024. eCollection 2025 May.
4
Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis.接受抗纤维化治疗的进行性非特发性肺纤维化患者的治疗效果、耐受性和生存率分析。
Ann Thorac Med. 2025 Apr-Jun;20(2):98-107. doi: 10.4103/atm.atm_213_24. Epub 2025 Mar 31.
5
Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study.进行性肺纤维化的识别：一项改良德尔菲研究的共识结果
Respir Res. 2024 Dec 31;25(1):448. doi: 10.1186/s12931-024-03070-z.
6
Inbuilt Errors: A Call for Standardized Definitions.内在错误：呼吁标准化定义。
Am J Respir Crit Care Med. 2025 Apr;211(4):663-664. doi: 10.1164/rccm.202411-2183LE.
7
The providing multidisciplinary ILD diagnoses (PROMISE) study - study design of the national registry of Japan facilitating interactive online multidisciplinary discussion diagnosis.提供多学科间ILD 诊断（PROMISE）研究——日本国家注册处的研究设计，促进在线互动多学科讨论诊断
BMC Pulm Med. 2024 Oct 14;24(1):511. doi: 10.1186/s12890-024-03232-1.
8
Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report.肺纤维化利益相关者峰会：NHLBI、三湖基金会和肺纤维化基金会联合研讨会报告。
Am J Respir Crit Care Med. 2024 Feb 15;209(4):362-373. doi: 10.1164/rccm.202307-1154WS.
9
Diagnosis of interstitial lung disease (ILD) secondary to systemic sclerosis (SSc) and rheumatoid arthritis (RA) and identification of 'progressive pulmonary fibrosis' using chest CT: a narrative review.系统性硬化症（SSc）和类风湿关节炎（RA）继发间质性肺疾病（ILD）的诊断及胸部 CT 对“进行性肺纤维化”的识别：叙述性综述。
Clin Exp Med. 2023 Dec;23(8):4721-4728. doi: 10.1007/s10238-023-01202-1. Epub 2023 Oct 6.
10
Reply to Cottin , to Johannson , to Scholand and Wells, and to Crowley .回复科廷、约翰松、肖兰德和韦尔斯，以及克劳利。
Am J Respir Crit Care Med. 2023 Jun 1;207(11):1542-1543. doi: 10.1164/rccm.202305-0786LE.
本文引用的文献
1
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化（更新版）和成人进展性肺纤维化：美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
2
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.吡非尼酮治疗非特发性肺纤维化的进展性肺纤维化间质性肺疾病患者（RELIEF）：一项双盲、随机、安慰剂对照、2b 期试验。
Lancet Respir Med. 2021 May;9(5):476-486. doi: 10.1016/S2213-2600(20)30554-3. Epub 2021 Mar 30.
3
Spectrum of Fibrotic Lung Diseases.纤维化性肺疾病谱
N Engl J Med. 2020 Sep 3;383(10):958-968. doi: 10.1056/NEJMra2005230.
4
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.吡非尼酮治疗无法分类的进行性纤维化间质性肺疾病患者：一项双盲、随机、安慰剂对照、2 期临床试验。
Lancet Respir Med. 2020 Feb;8(2):147-157. doi: 10.1016/S2213-2600(19)30341-8. Epub 2019 Sep 29.
5
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.尼达尼布治疗进行性纤维化间质性肺疾病。
N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
6
What's in a name? That which we call IPF, by any other name would act the same.名字有何意义？无论我们如何称呼特发性肺纤维化（IPF），它的表现都是一样的。
Eur Respir J. 2018 May 17;51(5). doi: 10.1183/13993003.00692-2018. Print 2018 May.
Zotero 插件